Search company, investor...

Founded Year

2020

Stage

Series B | Alive

Total Raised

$161.65M

Last Raised

$88.65M | 2 mos ago

About BlossomHill Therapeutics

BlossomHill Therapeutics focuses on small molecule drug discovery and development, operating within the healthcare and pharmaceutical industry. The company's main services involve addressing unmet medical needs in the fields of oncology and autoimmune disorders through its expertise in drug design and development. It was founded in 2020 and is based in San Diego, California.

Headquarters Location

3525 John Hopkins Court Suite 100

San Diego, California, 92121,

United States

858-732-3880

Loading...

Loading...

BlossomHill Therapeutics Patents

BlossomHill Therapeutics has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/8/2021

Application

Application Date

7/8/2021

Grant Date

Title

Related Topics

Status

Application

Latest BlossomHill Therapeutics News

BlossomHill Therapeutics Chief Executive Officer, Jingrong Jean Cui, Ph.D., Elected to the National Academy of Engineering

Feb 14, 2024

SAN DIEGO--(BUSINESS WIRE)--BlossomHill Therapeutics, a biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune diseases, today announced Jingrong Jean Cui, Ph.D., Co-Founder, President and Chief Executive Officer of BlossomHill Therapeutics, has been elected to the National Academy of Engineering (NAE). The prestigious honor recognizes Dr. Cui’s direct role in the innovation of new medicines to fight cancer and address urgent m

BlossomHill Therapeutics Frequently Asked Questions (FAQ)

  • When was BlossomHill Therapeutics founded?

    BlossomHill Therapeutics was founded in 2020.

  • Where is BlossomHill Therapeutics's headquarters?

    BlossomHill Therapeutics's headquarters is located at 3525 John Hopkins Court, San Diego.

  • What is BlossomHill Therapeutics's latest funding round?

    BlossomHill Therapeutics's latest funding round is Series B.

  • How much did BlossomHill Therapeutics raise?

    BlossomHill Therapeutics raised a total of $161.65M.

  • Who are the investors of BlossomHill Therapeutics?

    Investors of BlossomHill Therapeutics include OrbiMed Advisors, Vivo Capital, Amkey Ventures, Colt Ventures, Hercules BioVentures Partners and 3 more.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.